Use of aspirin as primary prevention of cardiovascular events [2]

JAMA

Volumn 296, Issue 4, 2006, Pages 391-

  Dalen, James E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG DOSE REGIMEN; HEART INFARCTION; HUMAN; INCIDENCE; LETTER; META ANALYSIS; PRIORITY JOURNAL; SEX DIFFERENTIATION; SYSTEMATIC REVIEW; FEMALE; MALE; NOTE;

ASPIRIN; FEMALE; HUMANS; MALE; META-ANALYSIS; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS;

EID: 33746457919     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.4.391-b     Document Type: Letter

References (2)

1. Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006;295:306-313.
2. Dalen JE. Aspirin to prevent heart attack and stroke: what is the right dose? Am J Med. 2006;119:198-202.